Paradigm Peptides / Amino Asylum (Matthew Kawa + Jennifer Stechkober)
This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Documented as December 10, 2025. Sources for this entry are named inline below and numbered in full on the parent archive page.
Matthew Kawa (owner of both Paradigm Peptides and Amino Asylum) and Jennifer Stechkober (Kawa’s sister, also employed at both entities) pleaded guilty in the Northern District of Indiana (Judge Cristal C. Brisco, US District Court, South Bend) to federal charges related to the distribution of unapproved new drugs and the mislabeling of testosterone as SARMs. Sentencing was scheduled for July 30, 2026.
This was a multi-brand plea: a single pair of defendants owned and operated two of the larger grey-market peptide brands simultaneously. The 6-month timeline from the June 2025 Amino Asylum raid to the December 2025 plea matched the pattern established in the Tailor Made case.
Why it still matters: confirmed the raid-to-plea-to-forfeiture cadence as a ~6-month pattern. Also exposed the cross-ownership structure that was common but rarely documented, one operator running multiple customer-facing brands that appeared unrelated on their public websites.
Primary sources: DOJ USAO Northern District of Indiana case page for United States v. Matthew Kawa et al..